Search Results 311-320 of 17160 for monoclonal antibody

  1. Publications - David L. Murray, M.D., Ph.D. - Mayo Clinic

    Monoclonal and oligoclonal anti-platelet factor 4 antibodies mediate VITT. ... monoclonal antibody interference. Blood 2018 Aug 9; 132 (6):670-672 Epub ...

  2. Dostarlimab-gxly (intravenous route) - Side effects & uses - Mayo Clinic

    Dostarlimab-gxly is a monoclonal antibody that changes the immune system to help control the growth of cancer cells. This medicine is to be given only by or ...

  3. Nasopharyngeal Carcinoma Clinical Trials

    Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor ...

  4. Radiation Therapy, Paclitaxel, and Carboplatin with or without Trastuzumab in Treating Patients with Esophageal Cancer - Mayo Clinic

    Monoclonal antibodies, such as trastuzumab, can block tumor growth in different ways. ... monoclonal antibody; Previous history of congestive heart failure ...

  5. Gastrointestinal manifestations of common variable immunodeficiency - Mayo Clinic

    The list of medications associated with hypogammaglobulinemia includes chronic glucocorticosteroids and sulfasalazine, anti-CD20 monoclonal antibodies ( ...

  6. Trastuzumab-dttb (intravenous route) - Side effects & uses - Mayo Clinic

    Trastuzumab-dttb is a monoclonal antibody. It interferes with the growth of cancer cells, which are eventually destroyed by the body. Since the growth of ...

  7. Duvelisib and Nivolumab for the Treatment of Stage IIB-IVB Mycosis Fungoides and Sezary Syndrome - Mayo Clinic

    Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

  8. A Study of Pembrolizumab and Ruxolitinib Phosphate for Treating Patients with Metastatic Stage IV Triple Negative Breast Cancer - Mayo Clinic

    Monoclonal antibodies, such as pembrolizumab, may interfere with the ... Has had a prior anti-cancer monoclonal antibody (mAb) ≤4 weeks prior to ...

  9. Dinutuximab (intravenous route) - Side effects & uses - Mayo Clinic

    This medicine is a GD2-binding monoclonal antibody. This medicine is to be given only by or under the direct supervision of your doctor. This product is ...

  10. Skin Cancer Clinical Trials

    Monoclonal antibodies, such as ipilimumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor ...